253
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of the Effect of Patient Preparation Using Castor Oil on ADC Value of Focal Liver Lesion

ORCID Icon, ORCID Icon, &
Pages 469-474 | Published online: 16 Feb 2021

References

  • Pankaj Jain T, Kan TW, Edward S, Fernon H, Kansan Naider R. Evaluation of ADC(ratio) on liver MRI diffusion to discriminate benign versus malignant solid liver lesions. Eur J Radiol Open. 2018;5:209–214. doi:10.1016/j.ejro.2018.10.002
  • Gelebek Yilmaz F, Yildirim AE. Relative contribution of Apparent Diffusion Coefficient (ADC) values and ADC ratios of focal hepatic lesions in the characterization of benign and malignant lesions. Eur J Ther. 2018;24(3):150–157. doi:10.5152/EurJTher.2018.438
  • Bharwani N, Koh DM. Diffusion-weighted imaging of the liver: an update. Cancer Imaging. 2013;13(2):171–185. doi:10.1102/1470-7330.2013.0019
  • Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, et al. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol. 2012;22(11):2514–2524. doi:10.1007/s00330-012-2519-x
  • Kaya B, Koc Z. Diffusion-weighted MRI and optimal b-value for characterization of liver lesions. Acta Radiol. 2014;55(5):532–542. doi:10.1177/0284185113502017
  • Taouli B, Koh D-M. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254(1):47–66. doi:10.1148/radiol.09090021
  • Namimoto T, Nakagawa M, Kizaki Y, et al. Characterization of liver tumors by diffusion-weighted imaging: comparison of diagnostic performance using the mean and minimum apparent diffusion coefficient. J Comput Assist Tomogr. 2015;39(4):453–461. doi:10.1097/RCT.0000000000000228
  • Jahic E, Sofic A, Selimovic AH. DWI/ADC in differentiation of benign from malignant focal liver lesion. Acta Informatica Medica. 2016;24(4):244–247. doi:10.5455/aim.2016.24.244-247
  • Testa ML, Chojniak R, Sene LS, et al. Is DWI/ADC a useful tool in the characterization of focal hepatic lesions suspected of malignancy? PLoS One. 2014;9(7):1–5. doi:10.1371/journal.pone.0101944
  • Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20(2):379–397. doi:10.1148/radiographics.20.2.g00mc01379
  • Tokgoz O, Unlu E, Unal I, et al. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver. African Health Sciences. 2016;16:227–233. doi:10.4314/ahs.v16i1.30
  • Schmeel FC. Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: is there a potential consensus that can help reducing the limits of expected bias? Eur Radiol. 2019;29(5):2243–2245. doi:10.1007/s00330-018-5866-4
  • Girometti R, Furlan A, Esposito G, et al. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging. 2008;28(2):411–419. doi:10.1002/jmri.21461
  • Inan N, Kilinc F, Sarisoy T, Gumustas S, Akansel G, Demirci A. Diffusion weighted MR imaging in the differential diagnosis of haemangiomas and metastases of the liver. Radiol Oncol. 2010;44(1). doi:10.2478/v10019-010-0001-4
  • Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol. 1999;173(2):393–398. doi:10.2214/ajr.173.2.10430143
  • Sasaki M, Yamada K, Watanabe Y, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology. 2008;249(2):624–630. doi:10.1148/radiol.2492071681
  • Peña-Nogales Ó, Hernando D, Aja-Fernández S, Luis-Garcia R. Determination of optimized set of b-values for apparent diffusion coefficient mapping in liver diffusion-weighted MRI. J Magn Reson. 2020;310:106634. doi:10.1016/j.jmr.2019.106634
  • Mürtz P, Flacke S, Träber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology. 2002;224(1):258–264. doi:10.1148/radiol.2241011117
  • Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol. 2008;18(3):477–485. doi:10.1007/s00330-007-0785-9
  • Scurr ED, Collins DJ, Temple L, Karanjia N, Leach MO, Koh D-M. Appearances of colorectal hepatic metastases at diffusion-weighted MRI compared with histopathology: initial observations. Br J Radiol. 2012;85(1011):225–230. doi:10.1259/bjr/11597735
  • Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications. RadioGraphics. 2009;29(6):1797–1810. doi:10.1148/rg.296095521
  • Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008;246(3):812–822. doi:10.1148/radiol.2463070432
  • Galea N, Cantisani V, Taouli B. Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging. 2013;37(6):1260–1276. doi:10.1002/jmri.23947
  • Klotz T, Montoriol P, Ines D, Petitcolin V, Joubert-zakeyh J, Garcier J. Hepatic haemangioma: common and uncommon imaging features. Diagn Interv Imaging. 2013;94(9):849–859. doi:10.1016/j.diii.2013.04.008
  • Coskun M, Mehralivand S, Shih JH, et al. Impact of bowel preparation with Fleet’sTM enema on prostate MRI quality. Abdom Radiol. 2020;45(12):4252–4259. doi:10.1007/s00261-020-02487-6
  • Dai M, Zhang T, Li Q, et al. The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial. Trials. 2019;20(1):1. doi:10.1186/s13063-018-3101-x
  • Ghazikhanlou Sani K, Jafari M-R, Shams S. A comparison of the efficacy, adverse effects, and patient compliance of the sena-graph®syrup and castor oil regimens for bowel preparation. Iran J Pharm Res. 2010;9(2):193–198.
  • Burdock GA, Carabin IG, Griffiths JC. Toxicology and pharmacology of sodium ricinoleate. Food Chem Toxicol. 2006;44(10):1689–1698. doi:10.1016/j.fct.2006.05.007
  • Johnson W. Final report on the safety assessment of Ricinus communis (castor) seed oil, hydrogenated castor oil, glyceryl ricinoleate, glyceryl ricinoleate SE, ricinoleic acid, potassium ricinoleate, sodium ricinoleate, zinc ricinoleate, cetyl ricinoleate, ethyl ricinoleate, glycol ricinoleate, isopropyl ricinoleate, methyl ricinoleate, and octyldodecyl ricinoleate1. Int J Toxicol. 2007;26(Suppl 3):31–77. doi:10.1080/10915810701663150
  • Alookaran J, Tripp J. Castor Oil. Treasure Island (FL); 2020.
  • Mamone G, Di Piazza A, Carollo V, et al. Imaging of hepatic hemangioma: from A to Z. Abdom Radiol (New York). 2020;45(3):672–691.
  • Caseiro-Alves F, Brito J, Araujo AE, et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol. 2007;17(6):1544–1554. doi:10.1007/s00330-006-0503-z
  • Luo M, Zhang L, Jiang X, Zhang W-D. Intravoxel incoherent motion diffusion-weighted imaging: evaluation of the differentiation of solid hepatic lesions. Transl Oncol. 2017;10(5):831–838. doi:10.1016/j.tranon.2017.08.003
  • Koh D-M, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188(6):1622–1635. doi:10.2214/AJR.06.1403